Epilepsy is one of the commonest neurological conditions. For historical reasons, this condition is often managed in the UK by non-specialists. Treatment options have increased markedly in the last 15 years, with a resultant increase in the potential for better seizure control and an enhanced quality of life for patients with epilepsy
Levetiracetam (LEV) is effective for treating localisation-related epilepsy, but it is uncertain whe...
With epilepsy being one of the most common neurological disorders, there is constant research hoping...
SummarySix patients with status epilepticus (SE) of various etiologies refractory to at least two an...
Epilepsy is a common clinical problem in patients with brain tumours, strongly affecting patients’ q...
ABSTRACT − Physicians treating patients with epilepsy have a host of thera-peutic options. Drug choi...
AbstractLevetiracetam is highly effective as add-on treatment in refractory partial-onset seizures b...
AbstractThis prospective open-label study used flexible dosing schedules of levetiracetam (LEV) in p...
Levetiracetam is highly effective as add-on treatment in refractory partial-onset seizures but there...
Basic properties of Levetiracetam (LEV) were described and own experience of its application at the ...
AbstractThis prospective observational study explored the efficacy and tolerability of levetiracetam...
OBJECTIVE: To prospectively assess the safety and efficacy of levetiracetam in patients with uncontr...
Objective - This prospective, open-label study was conducted to evaluate the effectiveness, tolerabi...
With the advent of new antiepileptic drugs comes the potential for significant advances in the emerg...
AbstractBackgroundThe role of new antiepileptic drugs (AED) in the treatment of status epilepticus (...
Abstract Background Epilepsy is a major symptom in patients with glioma. Levetiracetam (LEV) is reco...
Levetiracetam (LEV) is effective for treating localisation-related epilepsy, but it is uncertain whe...
With epilepsy being one of the most common neurological disorders, there is constant research hoping...
SummarySix patients with status epilepticus (SE) of various etiologies refractory to at least two an...
Epilepsy is a common clinical problem in patients with brain tumours, strongly affecting patients’ q...
ABSTRACT − Physicians treating patients with epilepsy have a host of thera-peutic options. Drug choi...
AbstractLevetiracetam is highly effective as add-on treatment in refractory partial-onset seizures b...
AbstractThis prospective open-label study used flexible dosing schedules of levetiracetam (LEV) in p...
Levetiracetam is highly effective as add-on treatment in refractory partial-onset seizures but there...
Basic properties of Levetiracetam (LEV) were described and own experience of its application at the ...
AbstractThis prospective observational study explored the efficacy and tolerability of levetiracetam...
OBJECTIVE: To prospectively assess the safety and efficacy of levetiracetam in patients with uncontr...
Objective - This prospective, open-label study was conducted to evaluate the effectiveness, tolerabi...
With the advent of new antiepileptic drugs comes the potential for significant advances in the emerg...
AbstractBackgroundThe role of new antiepileptic drugs (AED) in the treatment of status epilepticus (...
Abstract Background Epilepsy is a major symptom in patients with glioma. Levetiracetam (LEV) is reco...
Levetiracetam (LEV) is effective for treating localisation-related epilepsy, but it is uncertain whe...
With epilepsy being one of the most common neurological disorders, there is constant research hoping...
SummarySix patients with status epilepticus (SE) of various etiologies refractory to at least two an...